122 related articles for article (PubMed ID: 10452314)
1. Quantification of glucose transport and phosphorylation in human skeletal muscle using FDG PET.
Reinhardt M; Beu M; Vosberg H; Herzog H; Hübinger A; Reinauer H; Müller-Gärtner HW
J Nucl Med; 1999 Jun; 40(6):977-85. PubMed ID: 10452314
[TBL] [Abstract][Full Text] [Related]
2. Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes.
Williams KV; Bertoldo A; Kinahan P; Cobelli C; Kelley DE
Diabetes; 2003 Jul; 52(7):1619-26. PubMed ID: 12829624
[TBL] [Abstract][Full Text] [Related]
3. Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model.
Bertoldo A; Peltoniemi P; Oikonen V; Knuuti J; Nuutila P; Cobelli C
Am J Physiol Endocrinol Metab; 2001 Sep; 281(3):E524-36. PubMed ID: 11500308
[TBL] [Abstract][Full Text] [Related]
4. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
[TBL] [Abstract][Full Text] [Related]
5. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
6. Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.
Kelley DE; Williams KV; Price JC; Goodpaster B
J Nucl Med; 1999 Nov; 40(11):1798-804. PubMed ID: 10565773
[TBL] [Abstract][Full Text] [Related]
7. Lumped constant for [(18)F]fluorodeoxyglucose in skeletal muscles of obese and nonobese humans.
Peltoniemi P; Lönnroth P; Laine H; Oikonen V; Tolvanen T; Grönroos T; Strindberg L; Knuuti J; Nuutila P
Am J Physiol Endocrinol Metab; 2000 Nov; 279(5):E1122-30. PubMed ID: 11052968
[TBL] [Abstract][Full Text] [Related]
8. Organ-specific insulin resistance in patients with noninsulin-dependent diabetes mellitus and hypertension.
Yokoyama I; Ohtake T; Momomura S; Yonekura K; Yamada N; Nishikawa J; Sasaki Y; Omata M
J Nucl Med; 1998 May; 39(5):884-9. PubMed ID: 9591594
[TBL] [Abstract][Full Text] [Related]
9. [Determination of regional rate of glucose metabolism in lumbar muscles in patients with generalized tendomyopathy using dynamic 18F-FDG PET].
Frey LD; Locher JT; Hrycaj P; Stratz T; Kovac C; Mennet P; Müller W
Z Rheumatol; 1992; 51(5):238-42. PubMed ID: 1476008
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance in liver cirrhosis. Positron-emission tomography scan analysis of skeletal muscle glucose metabolism.
Selberg O; Burchert W; vd Hoff J; Meyer GJ; Hundeshagen H; Radoch E; Balks HJ; Müller MJ
J Clin Invest; 1993 May; 91(5):1897-902. PubMed ID: 8486761
[TBL] [Abstract][Full Text] [Related]
11. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia.
Yokoyama I; Ohtake T; Momomura S; Yonekura K; Kobayakawa N; Aoyagi T; Sugiura S; Yamada N; Ohtomo K; Sasaki Y; Omata M; Yazaki Y
J Nucl Med; 1999 Jul; 40(7):1116-21. PubMed ID: 10405129
[TBL] [Abstract][Full Text] [Related]
12. The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle.
Kelley DE; Mintun MA; Watkins SC; Simoneau JA; Jadali F; Fredrickson A; Beattie J; Thériault R
J Clin Invest; 1996 Jun; 97(12):2705-13. PubMed ID: 8675680
[TBL] [Abstract][Full Text] [Related]
13. Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model.
Williams KV; Bertoldo A; Mattioni B; Price JC; Cobelli C; Kelley DE
J Clin Endocrinol Metab; 2003 Mar; 88(3):1271-9. PubMed ID: 12629118
[TBL] [Abstract][Full Text] [Related]
14. Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with microdialysis.
Virtanen KA; Peltoniemi P; Marjamäki P; Asola M; Strindberg L; Parkkola R; Huupponen R; Knuuti J; Lönnroth P; Nuutila P
Diabetologia; 2001 Dec; 44(12):2171-9. PubMed ID: 11793018
[TBL] [Abstract][Full Text] [Related]
15. Time course of skeletal muscle glucose uptake during euglycemic hyperinsulinemia in the anesthetized rabbit: a fluorine-18-2-deoxy-2-fluoro-D-glucose study.
Mossberg KA; Taegtmeyer H
J Nucl Med; 1992 Aug; 33(8):1523-9. PubMed ID: 1634945
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma.
Minn H; Nuutila P; Lindholm P; Ruotsalainen U; Bergman J; Teräs M; Knuuti MJ
Cancer; 1994 Mar; 73(5):1490-8. PubMed ID: 8111717
[TBL] [Abstract][Full Text] [Related]
17. Brain glucose metabolism in noninsulin-dependent diabetes mellitus: a study in Pima Indians using positron emission tomography during hyperinsulinemia with euglycemic glucose clamp.
Eastman RC; Carson RE; Gordon MR; Berg GW; Lillioja S; Larson SM; Roth J
J Clin Endocrinol Metab; 1990 Dec; 71(6):1602-10. PubMed ID: 2229317
[TBL] [Abstract][Full Text] [Related]
18. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
[TBL] [Abstract][Full Text] [Related]
19. Insulin regulation of glucose transport and phosphorylation in skeletal muscle assessed by PET.
Kelley DE; Williams KV; Price JC
Am J Physiol; 1999 Aug; 277(2):E361-9. PubMed ID: 10444433
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
Laine H; Yki-Jarvinen H; Kirvela O; Tolvanen T; Raitakari M; Solin O; Haaparanta M; Knuuti J; Nuutila P
J Clin Invest; 1998 Mar; 101(5):1156-62. PubMed ID: 9486987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
